Kaposi's sarcoma after renal transplantation: treatment with liposomal doxorubicin.
Boehringer
M
M
Schwarz
A
A
Keller
F
F
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage*; D004337:Drug Carriers; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016030:Kidney Transplantation / Q000009:adverse effects*; D008081:Liposomes; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology*; D016559:Tacrolimus / Q000008:administration & dosage
D000970:Antineoplastic Agents; D004337:Drug Carriers; D007166:Immunosuppressive Agents; D008081:Liposomes; D004317:Doxorubicin; D016572:Cyclosporine; D016559:Tacrolimus